GlassScriptPhysician profile
Richard P Brown
NPI 1922055862
$9,085.38
in general payments reported to CMS, 2019-2025
40 companies · $440 in 2025
The $440 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,584 · 2020: $813 · 2021: $1,642 · 2022: $1,497 · 2023: $1,575 · 2024: $1,534 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,549.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,065.42 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $1,020.16 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $928.10 | 2019-2025 | |
| Biotronik INC. | $875.17 | 2019-2024 | Amvia Edge |
| Boston Scientific Corporation | $639.63 | 2019-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $593.92 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $558.91 | 2021-2024 | Verquvo |
| Henry Schein, INC. | $469.44 | 2019 | |
| Pfizer INC. | $413.53 | 2019-2025 | |
| Irhythm Technologies, INC. | $284.40 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| E.R. Squibb & Sons, L.L.C. | $253.38 | 2019-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $220.78 | 2019-2024 | Farxiga |
| Novo Nordisk INC | $215.86 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $197.82 | 2019-2024 | Lifevest |
| Medtronic, INC. | $128.04 | 2023-2025 | Linq II |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.